Herbal Extract Formulation for Herpesvirus Infection Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for herpesvirus infections, such as those caused by HSV-1, HSV-2, and VZV, often have adverse side effects and can lead to resistant viruses, especially with long-term use, and do not effectively address both symptom relief and antiviral activity.
Innovation Solution
A topical formulation comprising extracts of Rheum palmatum, Chrysanthemum indicum, and Sanguisorba officinalis, potentially combined with acyclovir, is used to treat and prevent herpesvirus infections, including oral herpes, genital herpes, and shingles, with a synergistic effect demonstrated in inhibiting viral replication.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If acyclovir is used for long-term treatment of herpesvirus infections, then antiviral activity is improved, but resistant viruses develop and side effects increase
Solution Approach 1:
The patent combines multiple herbal extracts (Rheum palmatum, Chrysanthemum indicum, Sanguisorba officinalis) with acyclovir to create a composite formulation. This composite approach provides synergistic antiviral activity while reducing the development of resistance and minimizing side effects compared to using acyclovir alone.
Solution Approach 2:
The patent modifies the chemical composition parameters by incorporating specific herbal extracts with known antiviral properties. These parameter changes enhance the overall antiviral efficacy and alter the pharmacological profile to reduce resistance development and side effects.
2Ease of operation
If topical agents such as paracetamol and lidocaine are used for oral herpes treatment, then symptom relief is improved, but direct antiviral activity is lost
Solution Approach 1:
The herbal extract formulation serves multiple functions simultaneously: it provides symptomatic relief through anti-inflammatory and analgesic properties of the herbs, while also maintaining direct antiviral activity against herpesvirus replication. This multi-functionality eliminates the need to choose between symptom relief and antiviral efficacy.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Disclosed is a formulation comprising at least two of Rheum palmatum, Chrysanthemum indicum and Sanguisorba officinalis extracts or prevalent molecules therefrom and a pharmaceutically acceptable carrier. Further disclosed is a formulation comprising one or more of Rheum palmatum, Chrysanthemum indicum and Sanguisorba officinalis extracts, or prevalent molecules therefrom in combination with acyclovir and a pharmaceutically acceptable carrier.Disclosed also is a method for treating herpesvirus infections by administering a formulation comprising extracts of Rheum palmatum, Chrysanthemum indicum or Sanguisorba officinalis extracts or prevalent molecules therefrom with or without an antiviral agent, such as acyclovir and a pharmaceutically acceptable carrier.